Sweetener Tied to Clotting Dangers

A “natural” zero-calorie sweetener that regulators waved through as safe is now tied to blood-clotting signals that should make health-conscious Americans read labels twice.

Quick Take

A 2023 Cleveland Clinic study linked higher blood levels of erythritol to roughly doubled risk of major heart-related events in a high-risk patient group.
Researchers reported a single typical serving can spike erythritol blood levels dramatically and keep them elevated for days, alongside lab signals of increased clotting.
FDA’s 2001 “Generally Recognized as Safe” (GRAS) status remains in place, even as calls grow for stronger long-term testing and clearer consumer information.
A 2025 study added new concern by finding erythritol exposure stressed human brain microvascular cells and reduced nitric oxide, a key blood-flow regulator.

What the Cleveland Clinic study found—and what it did not

Cleveland Clinic researchers reported in 2023 that people with higher circulating erythritol levels faced a higher rate of major adverse cardiovascular events over three years, including heart attack and stroke, in a cohort already at elevated cardiac risk. The analysis was observational, meaning it identified an association rather than proving erythritol directly caused those outcomes. Even so, the researchers paired the clinical link with mechanistic lab work that raised new safety questions.

The same research team tested erythritol’s effects in the lab and described increased platelet-related activity consistent with clot formation, along with animal-model findings suggesting faster clot development after vascular injury. They also reported that a drink-sized dose used in a small human experiment significantly raised blood levels for more than two days. That detail matters because erythritol is marketed as a harmless swap—yet exposure may not be as brief as consumers assume.

How erythritol became “everywhere” under a GRAS system

Erythritol is a sugar alcohol found naturally in small amounts in some foods, but modern diets often deliver it at industrial scale through processed “sugar-free,” low-carb, and keto-labeled products. The FDA accepted erythritol as GRAS in 2001, a regulatory lane that does not necessarily mirror the kind of long, expensive testing Americans expect for drugs. That gap fuels frustration among consumers who thought “natural” labeling meant thoroughly verified.

Food makers leaned into erythritol because it sweetens without calories and generally avoids the stomach problems associated with some other sugar alcohols. The policy question is whether the GRAS pathway and the marketplace moved faster than long-term independent science, especially for older Americans managing diabetes, weight, or heart risk. The available research does not justify panic, but it does justify skepticism toward broad “safe for everyone” assumptions.

2025 research adds a new angle: blood-vessel function in the brain

In 2025, the American Physiological Society highlighted research showing erythritol exposure in human brain microvascular endothelial cells increased oxidative stress and reduced nitric oxide availability. Nitric oxide is central to healthy vessel relaxation and blood flow, so reduced levels can be a warning sign for vascular dysfunction. This work did not track heart attacks or strokes in real people, but it widened the concern beyond clotting into endothelial health.

What cautious consumers can do now while regulators catch up

Americans trying to control sugar intake face a real bind: excess sugar is a known problem, but “zero-calorie” substitutes can carry unanswered risks. The strongest evidence so far centers on high exposure and high-risk populations, and experts have emphasized the need for randomized controlled trials before drawing final causal conclusions. Until then, moderation is a practical safeguard: limit frequent high-dose intake, watch portion sizes, and treat “keto” sweets as treats.

For families trying to make good choices, the immediate step is simple: check ingredient lists for erythritol in packaged snacks, protein bars, and diet drinks, especially if you already have cardiovascular risk factors. Consumers can also push for clearer labeling and more rigorous review standards so safety isn’t assumed simply because an ingredient is popular or profitable. Limited government should still mean competent oversight—focused on real harms, not political fads.